{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:25:30Z","timestamp":1792686330291,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.lungcan.2024.107822","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T21:38:31Z","timestamp":1715636311000},"page":"107822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Optimal management of radiation pneumonitis: Findings of an international Delphi consensus study"],"prefix":"10.1016","volume":"192","author":[{"given":"Indu S.","family":"Voruganti Maddali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cicely","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houda","family":"Bahig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"L. M. Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Evison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5617-9781","authenticated-orcid":false,"given":"Corinne","family":"Faivre-Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9468-7947","authenticated-orcid":false,"given":"Kevin","family":"Franks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Harden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Videtic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Percy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3995-2204","authenticated-orcid":false,"given":"Suresh","family":"Senan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar","family":"Siva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3258-1869","authenticated-orcid":false,"given":"Jacqueline","family":"Kruser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6006-2372","authenticated-orcid":false,"given":"Timothy","family":"Kruser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8450-3892","authenticated-orcid":false,"given":"Clive","family":"Peedell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Melody Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2062-5417","authenticated-orcid":false,"given":"Stephen","family":"Harrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3569-9099","authenticated-orcid":false,"given":"Alexander V.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2024.107822_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2022.07.008","article-title":"The changing landscape of pneumonitis in non-small cell lung cancer","volume":"171","author":"Arifin","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2024.107822_b0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.semradonc.2020.11.006","article-title":"Biology of radiation-induced lung injury","volume":"31","author":"Roy","year":"2021","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.lungcan.2024.107822_b0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12890-020-01376-4","article-title":"Radiation-induced lung injury: current evidence","volume":"21","author":"Arroyo-Hernandez","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.lungcan.2024.107822_b0020","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijrobp.2012.04.043","article-title":"Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis","volume":"85","author":"Palma","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2024.107822_b0025","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijrobp.2003.09.045","article-title":"Target cells in radiation pneumopathy","volume":"58","author":"Trott","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2024.107822_b0030","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/cam4.3718","article-title":"Safety and efficacy of PD-1\/PD-L1 inhibitors combined with radiotherapy in patients with non-small-cell lung cancer: a systematic review and meta-analysis","volume":"10","author":"Geng","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.lungcan.2024.107822_b0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijrobp.2023.09.009","article-title":"Treatment-related pneumonitis of EGFR tyrosine kinase inhibitors plus thoracic radiation therapy in patients with non-small cell lung cancer: a systematic review and meta-analysis","volume":"118","author":"Meng","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2024.107822_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10070222","article-title":"Radiation pneumonitis: old problem, new tricks","volume":"10","author":"Jain","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lungcan.2024.107822_b0045","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3109\/0284186X.2012.718093","article-title":"A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis","volume":"51","author":"Vogelius","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.lungcan.2024.107822_b0050","article-title":"Immune checkpoint inhibitor and radiotherapy-related pneumonitis: an informatics approach to determine real-world incidence, severity, management, and resource implications","volume":"8","author":"Hindocha","year":"2021","journal-title":"Front Med (lausanne)"},{"key":"10.1016\/j.lungcan.2024.107822_b0055","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.21037\/jtd-20-1792","article-title":"Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer","volume":"12","author":"Hassanzadeh","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.lungcan.2024.107822_b0060","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.1038\/s41598-021-86863-2","article-title":"Evaluation of practical experiences of German speaking radiation oncologists in combining radiation therapy with checkpoint blockade","volume":"11","author":"Kraus","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.lungcan.2024.107822_b0065","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jtho.2020.05.001","article-title":"Treatment guidance for patients with lung cancer during the coronavirus 2019 pandemic","volume":"15","author":"Dingemans","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2024.107822_b0070","doi-asserted-by":"crossref","first-page":"e1800","DOI":"10.1002\/onco.13890","article-title":"Province-wide analysis of patient-reported outcomes for stage IV non-small cell lung cancer","volume":"26","author":"Tjong","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.lungcan.2024.107822_b0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.radonc.2004.02.015","article-title":"Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer\u2013a systematic review","volume":"71","author":"Rodrigues","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.lungcan.2024.107822_b0080","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijrobp.2012.04.043","article-title":"Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: An international individual patient data meta-analysis","volume":"85","author":"Palma","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2024.107822_b0085","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1200\/JCO.2012.42.0489","article-title":"American Society of Clinical Oncology Clinical Practice Guidelines: formal systematic review-based consensus methodology","volume":"30","author":"Loblaw","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2024.107822_b0090","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.prro.2017.10.008","article-title":"Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: Findings of an International Delphi Consensus Study","volume":"8","author":"Nguyen","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.lungcan.2024.107822_b0095","series-title":"Handbook of Research Methods in Health Social Sciences","first-page":"715","article-title":"The Delphi Technique","author":"Chalmers","year":"2019"},{"key":"10.1016\/j.lungcan.2024.107822_b0100","first-page":"1","article-title":"The Delphi technique: Making sense of consensus","volume":"12","author":"Hsu","year":"2007","journal-title":"Pract. Assess. Res. Eval."},{"key":"10.1016\/j.lungcan.2024.107822_b0105","unstructured":"Delbecq AL, Van de Ven AH, Gustafson DH. Group techniques for program planning: A guide to nominal group and Delphi processes. ed.: Scott, Foresman; 1975."},{"key":"10.1016\/j.lungcan.2024.107822_b0110","unstructured":"Health UDo, Services H. Common Terminology Criteria for Adverse Events. Version 5.0. Published November 27, 2017. In, 2020."},{"key":"10.1016\/j.lungcan.2024.107822_b0115","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ijrobp.2017.03.010","article-title":"Treatment-related toxicity in patients with early-stage non-small cell lung cancer and coexisting interstitial lung disease: a systematic review","volume":"98","author":"Chen","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2024.107822_b0120","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jtho.2020.02.005","article-title":"International association for the study of lung cancer advanced radiation technology C. A primer on interstitial lung disease and thoracic radiation","volume":"15","author":"Goodman","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2024.107822_b0125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3390\/cancers10080257","article-title":"Stereotactic body radiation therapy for patients with pulmonary interstitial change: high incidence of fatal radiation pneumonitis in a retrospective multi-institutional study","volume":"10","author":"Onishi","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.lungcan.2024.107822_b0130","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1016\/j.cllc.2017.06.021","article-title":"Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival in patients treated with lung stereotactic body radiation therapy (SBRT)","volume":"19","author":"Glick","year":"2018","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.lungcan.2024.107822_b0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0959-8049(97)00377-8","article-title":"Risk factors of pneumonitis following chemoradiotherapy for lung cancer","volume":"34","author":"Yamada","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lungcan.2024.107822_b0140","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2024.107822_b0145","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1148\/rg.244035160","article-title":"Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis","volume":"24","author":"Choi","year":"2004","journal-title":"Radiographics"},{"key":"10.1016\/j.lungcan.2024.107822_b0150","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2214\/ajr.150.4.765","article-title":"CT appearance of acute radiation-induced injury in the lung","volume":"150","author":"Ikezoe","year":"1988","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.lungcan.2024.107822_b0155","doi-asserted-by":"crossref","first-page":"e166S","DOI":"10.1378\/chest.12-2395","article-title":"Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Brunelli","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2024.107822_b0160","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/JTO.0b013e3181a99ff6","article-title":"Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients","volume":"4","author":"Stephans","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2024.107822_b0165","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ijrobp.2007.12.051","article-title":"Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer","volume":"72","author":"Henderson","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2024.107822_b0170","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2016.68.2005","article-title":"Pneumonitis in patients treated with anti-programmed death-1\/programmed death ligand 1 therapy","volume":"35","author":"Naidoo","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2024.107822_b0175","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S1470-2045(22)00508-3","article-title":"Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial","volume":"23","author":"Hui","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lungcan.2024.107822_b0180","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2024.107822_b0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.prro.2022.07.003","article-title":"Use of glucocorticoids in patients with cancer: potential benefits, harms, and practical considerations for clinical practice","volume":"13","author":"Kim","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.lungcan.2024.107822_b0190","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2024.107822_b0195","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1200\/JCO.2000.18.19.3409","article-title":"Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: a meta-analysis of randomized evidence","volume":"18","author":"Ioannidis","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2024.107822_b0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM198307073090105","article-title":"Association of adrenocorticosteroid therapy and peptic-ulcer disease","volume":"309","author":"Messer","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2024.107822_b0205","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.chest.2019.03.033","article-title":"Radiation-induced lung injury: assessment and management","volume":"156","author":"Hanania","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2024.107822_b0210","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.ijrobp.2021.07.1691","article-title":"Predictors of pneumonitis after conventionally fractionated radiotherapy for locally advanced lung cancer","volume":"111","author":"McFarlane","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2024.107822_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(23)01384-3","article-title":"Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial","author":"Chang","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2024.107822_b0220","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2147\/CMAR.S136818","article-title":"Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis","volume":"9","author":"Chuzi","year":"2017","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.lungcan.2024.107822_b0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ctrv.2016.02.003","article-title":"Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy","volume":"45","author":"Eigentler","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.lungcan.2024.107822_b0230","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1188\/17.CJON.S2.53-59","article-title":"Toxicity management: development of a novel and immune-mediated adverse events algorithm","volume":"21","author":"Mistry","year":"2017","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.lungcan.2024.107822_b0235","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/annonc\/mdw141","article-title":"Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies","volume":"27","author":"Naidoo","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lungcan.2024.107822_b0240","unstructured":"Institute NIoHaNC. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. In: National Institutes of Health and National Cancer Institute, 2009."},{"key":"10.1016\/j.lungcan.2024.107822_b0245","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1200\/JCO.2014.60.0379","article-title":"Toxicities of immunotherapy for the practitioner","volume":"33","author":"Weber","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2024.107822_b0250","first-page":"422","article-title":"Clinical management of pneumonitis in patients receiving anti-PD-1\/PD-L1 therapy","volume":"9","author":"Bala-Hampton","year":"2018","journal-title":"J Adv Pract Oncol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224003568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224003568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T18:11:25Z","timestamp":1717524685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500224003568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":50,"alternative-id":["S0169500224003568"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107822","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal management of radiation pneumonitis: Findings of an international Delphi consensus study","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107822"}}